People with Parkinson's Disease.
Conditions
Interventions
Intervention group: each participant receives four sessions ofactive set-up, the tDCS device will apply a constant current of for 20 minutes with the ramp up-ramp down duration of 30 sec. the intensit
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosed with PD by a neurologist Age 40 or older Stages 1–3 on the Hoehn and Yahr scale Ability to walk independently for at least 10 m without using walking aids A score of = 24 on Montreal Cognitive Assessment (MoCA-P) No change in medication prescription 3 weeks prior to study and during the study
Exclusion criteria
Exclusion criteria: ny deformity of the lower limbs(2) using central nervous system medications other than for PD, e.g., antiepileptic or antidepressant drugs (3) Contraindications of using tDCS, such as having metal implants in the head, pacemaker, pregnancy, history of brain damage, history of epilepsy and seizures, and intermittent headaches (4) patients with neurological diseases other than PD, psychiatric diseases, or patients with drug or alcohol abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Berg balance scale score. Timepoint: before/after intervention. Method of measurement: Berg Balance Scale.;The score of Mini-BESTest (Balance Evaluation Systems Test). Timepoint: before/after intervention. Method of measurement: Mini-Balance Evaluation Systems Test.;Timed Up and Go Test. Timepoint: before/after intervention. Method of measurement: Timed Up and Go Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDR. Javid Mostamand
Esfahan University of Medical Sciences
Outcome results
None listed